Inhibition of experimental asthma by indoleamine 2,3-dioxygenase

Journal of Clinical Investigation

Volumn 114, Issue 2, 2004, Pages 270-279

  Hayashi, Tomoko ^a   Beck, Lucinda ^a   Rossetto, Cyprian ^a   Gong, Xing ^a   Takikawa, Osamu ^b   Takabayashi, Kenji ^a   Broide, David H ^a   Carson, Dennis A ^a   Raz, Eyal ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; LIGAND; TOLL LIKE RECEPTOR; TRYPTOPHAN;

ADOPTIVE TRANSFER; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

EID: 4043170040     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI21275     Document Type: Article

References (50)

1. Bach, J.F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. J. Engl. J. Med. 347:911-920.
2. Strachan, D.P. 1989. Hay fever, hygiene, and household size. BMJ. 299:1259-1260.
3. Howarth, P.H. 1998. Is allergy increasing? Early life influences. Clin. Exp. Allergy. 28(Suppl. 6):2-7.
4. Martinez, F.D., and Holt, P.G. 1999. Role of microbial burden in aetiology of allergy and asthma. Lancet. 354(Suppl. 2):S1112-S1115.
5. Weiss, S.T. 2002. Eat dirt: the hygiene hypothesis and allergic diseases. N. Engl. J. Med. 347:930-931.
6. Kemp, A., and Bjorksten, B. 2003. Immune deviation and the hygiene hypothesis: a review of the epidemiological evidence. Pediatr. Allergy Immunol. 14:74-80.
7. Shaheen, S.O., et al. 1996. Measles and atopy in Guinea-Bissau. Lancet. 347:1792-1796.
8. Shirakawa, T., Enomoto, T., Shimazu, S., and Hopkin, J.M. 1997. The inverse association between tuberculin responses and atopic disorder. Science. 275:77-79.
9. Godfrey, D.G. 1978. Identification of economically important parasites. Nature. 273:600-604.
10. Wills-Karp, M., Santeliz, J., and Karp, C.L. 2001. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat. Rev. Immunol. 1:69-75.
11. Takeda, K., Kaisho, T., and Akira, S. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
12. Hayashi, T., et al. 2001. Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase. Infect. Immun. 69:6156-6164.
13. Hissong, B.D., Byrne, G.I., Padilla, M.L., and Carlin, J.M. 1995. Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1. Cell. Immunol. 160:264-269.
14. Mellor, A.L., and Munn, D.H. 2001. Extinguishing maternal immune responses during pregnancy: implications for immunosuppression. Semin. Immunol. 13:213-218.
15. Grohmann, U., et al. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3:1097-1101.
16. Babcock, T.A., and Carlin, J.M. 2000. Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells. Cytokine. 12:588-594.
17. Hwu, P., et al. 2000. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164:3596-3599.
18. Munn, D.H., et al. 2002. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 297:1867-1870.
19. Mellor, A.L., et al. 2003. Induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 171:1652-1655.
20. Fallarino, F., et al. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4:1206-1212.
21. Munn, D.H., et al. 1998. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 281:1191-1193.
22. Munn, D.H., et al. 1999. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189:1363-1372.
23. Roman, M., et al. 1997. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3:849-854.
24. Takikawa, O., Tagawa, Y., Iwakura, Y., Yoshida, R., and Truscott, R.J. 1999. Interferon-gamma-dependent/independent expression of indoleamine 2,3-dioxygenase. Studies with interferon-gamma-knockout mice. Adv. Exp. Med. Biol. 467:553-557.
25. Fallarino, F., et al. 2002. T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9:1069-1077.
26. - cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am. J. Respir. Cell Mol. Biol. 30:311-318.
27. Lloyd, C.M., et al. 2000. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J. Exp. Med. 191:265-274.
28. Horner, A.A., Van Uden, J.H., Zubeldia, J.M., Broide, D., and Raz, E. 2001. DNA-based immunotherapeutics for the treatment of allergic disease. Immunol. Rev. 179:102-118.
29. Eisenbarth, S.C., et al. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:1645-1651.
30. Terness, P., et al. 2002. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196:447-457.
31. Frumento, G., et al. 2002. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196:459-468.
32. Caucheteux, S.M., Kanellopoulos-Langevin, C., and Ojcius, D.M. 2003. At the innate frontiers between mother and fetus: linking abortion with complement activation. Immunity. 18:169-172.
33. Barnes, P.J. 2001. Histamine and serotonin. Pulm. Pharmacol. Ther. 14:329-339.
34. Sedlmayr, P., et al. 2002. Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta. Mol. Hum. Reprod. 8:385-391.
35. Curotto de Lafaille, M.A., and Lafaille, J.J. 2002. CD4(+) regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14:771-778.
36. Broide, D.H., et al. 2001. Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma. J. Clin. Immunol. 21:175-182.
37. Daubener, W., et al. 2001. Restriction of Toxoplasmagondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect. Immun. 69:6527-6531.
38. Mackler, A.M., Barber, E.M., Takikawa, O., and Pollard, J.W. 2003. Indoleamine 2,3-dioxygenase is regulated by IFN-γ in the mouse placenta during Listeria monocytogenes infection. J. Immunol. 170:823-830.
39. Bodaghi, B., et al. 1999. Role of IFN-γ-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells. J. Immunol. 162:957-964.
40. van Kooyk, Y., and Geijtenbeek, T.B. 2003. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3:697-709.
41. Wakkach, A., et al. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity. 18:605-617.
42. Datta, S.K., et al. 2003. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J. Immunol. 170:4102-4110.
43. Takikawa, O., Kuroiwa, T., Yamazaki, F., and Kido, R. 1988. Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263:2041-2048.
44. Vermaelen, K.Y., Carro-Muino, I., Lambrecht, B.N., and Pauwels, R.A. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193:51-60.
45. Broide, D., et al. 1998. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J. Immunol. 161:7054-7062.
46. Ikeda, R.K., et al. 2003. Resolution of airway inflammation following ovalbumin inhalation: comparison of ISS DNA and corticosteroids. Am. J. Respir. Cell Mol. Biol. 28:655-663.
47. Cho, J.Y., et al. 2004. Immunostimulatory DNA inhibits transforming growth factor-β expression and airway remodeling. Am. J. Respir. Cell Mol. Biol. 30:651-661.
48. Hansen, G., Berry, G., DeKruyff, R-H., and Umetsu, D.T. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103:175-183.
49. Grogan, J.L., and Locksley, R.M. 2002. T helper cell differentiation: on again, off again. Curr. Opin. Immunol. 14:366-372.
50. Suzuki, S., et al. 2001. Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase in early concepts. Biochem. J. 355:425-429.